The differential adherence capabilities of two Listeria monocytogenes strains in monoculture and multispecies biofilms as a function of temperature von Norwood, D.E., Gilmour, A.

Volltext

Comparison of repetitive element sequence-based PCR with multilocus enzyme electrophoresis and pulsed field gel electrophoresis for typing Listeria monocytogenes food isolates von Harvey, J., Norwood, D.E., Gilmour, A.

Volltext

506TiP Pembrolizumab plus lenvatinib versus standard of care for previously treated metastatic colorectal cancer (mCRC): Phase III LEAP-017 study von Yoshino, T., Fu, R., Hawk, N., Adelberg, D.E., Norwood, K.G., Heinemann, V.

Volltext

438TiP MOUNTAINEER-03: Phase III study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer (trial in progress) von André, T., Bekaii-Saab, T., Tabernero, J., Siena, S., Yoshino, T., Norwood, K.G., Adelberg, D.E., Ward, J., Yang, S., Strickler, J.H., Van Cutsem, E.

Volltext

Estimating Time to ESRD in Children With CKD von Furth, Susan L., Pierce, Chris, White, Colin A., Wong, Craig S., Wühl, Elke, Abraham, Alison G., Warady, Bradley A., Samuels, Joshua, Furth, Susan, Atkinson, Meredith, Wilson, Amy, Quiroga, Alejandro, Massengill, Susan, Selewski, Dave, Kogon, Amy, Kaskel, Frederick, Saland, Jeffrey, Norwood, Victoria, Matoo, Tej, Hidalgo, Guillermo, Srivaths, Poyyapakkam, Carlson, Joann, Langman, Craig, Mendley, Susan, John, Eunice, Upadhyay, Kiran, Seo-Mayer, Patricia, Patterson, Larry, Kupferman, Juan, Misurac, Jason, Mongia, Anil, Kiessling, Steffan, Sanchez-Kazi, Cheryl, Dart, Allison, Fathallah, Sahar, Claes, Donna, Mitsnefes, Mark, Blydt-Hansen, Tom, Greenbaum, Larry, Flynn, Joseph, Salusky, Isidro, Yadin, Ora, Dell, Katherine, Jenkins, Randall, Pan, Cynthia, Ku, Elaine, Al-Uzri, Amira, Rodig, Nancy, Wong, Cynthia, Davis, Keefe, Turman, Martin, Bartosh, Sharon, Nayak, Anjali, Benador, Nadine, Mak, Robert, Wood, Ellen, Lerner, Gary, Barletta, Gina Marie, Bakkaloglu, A., Ozaltin, F., Peco-Antic, A., Gellermann, J., Sallay, P., Bonzel, K.-E., Wingen, A.-M., Żurowska, A., Balasz, I., Trivelli, A., Perfumo, F., Müller-Wiefel, D.E., Möller, K., Offner, G., Enke, B., Wühl, E., Hadtstein, C., Mehls, O., Schaefer, F., Emre, S., Caliskan, S., Wygoda, S., Jeck, N., Ardissino, G., Testa, S., Montini, G., Charbit, M., Fernandes-Teixeira, A., Matteucci, M.C., Mastrostefano, A., Wigger, M., Berg, U.B., Celsi, G., Fischbach, M., Terzic, J., Fydryk, J., Coppo, R., Arbeiter, K., Jankauskiené, A., Grenda, R., Janas, R., Neuhaus, T.J.

Volltext

MOUNTAINEER-03: Phase III study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+metastatic colorectal cancer (trial in progress) von Andre, T, Bekaii-Saab, T, Tabernero, J, Siena, S, Yoshino, T, Norwood, K.G, Adelberg, D.E, Ward, J, Yang, S, Strickler, J.H, Van Cutsem, E

Volltext